Inflammation-related prognostic markers in resected hepatocellular carcinoma
Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger · 2023
Read Inflammation-related prognostic markers in resected hepatocellular carcinoma by Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10746354.txt.
Description
Fabio Giannone and co-authors review, in a 2023 paper, inflammation linked markers that may predict how patients fare after surgery for liver cancer. This cancer is usually found late, and treatments remain unsatisfying, so it stays among the deadliest cancers worldwide. Surgery is a key option at early stages, yet five year survival after it is limited, in part because recurrence is hard to foresee.
Liver inflammation offers many candidate markers, in blood cell counts and in tissue traits. Some track survival and recurrence chances. The review sorts these tools and targets, and weighs what each marker really signals. It also covers gene expression signatures that may predict outcomes. The aim is firmer forecasts for liver surgeons and specialists. Better forecasts can guide who gets surgery, and how closely survivors are watched for return of disease.
Catalog record
| CREATOR | Fabio Giannone, Nevena Slovic, Patrick Pessaux, Catherine Schuster, Thomas F. Baumert, Joachim Lupberger |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |